ARCHIVES

CCIRC Fears Multimodality Studies Threatened By Cooperative Groups’ Misapplication Of Funds

This article is from The Cancer Letter archive.

Vol. 03 No. 02 | January 14, 1977

Download PDF Visit The Full Archive

Related Articles

Clinical Trials Approved By NCI

January 30, 2004

IDMC Recommends Halting Phase III Trial Of Onartuzumab in MET-Positive NSCLC

March 28, 2014

NCI, IOM Called To Congress to Explain Divergent Positions On Minority Research

January 29, 1999

Tobacco Control: Surgeon General Finds Increase In Smoking By Minority Teens

May 1, 1998

ASCO Annual Meeting: New Therapeutic Approaches To Breast Cancer Highlighted

June 25, 2004

Core Grants Limit Formula Must Wait On Profiles

January 27, 1978